Current high impact projects include:

  • Psychostimulants and the developing brain
  • Antidepressant drugs and neuronal adaptation
  • The gastrointestinal system and brain function (gut-brain axis)
  • Cerebellar mechanisms of Schizophrenia
  • Potassium channel mechanisms in neuropathology
  • Function of Niemann-Pick Disease Protein in lipid transport
  • Compartmental Stress Signalling in Age-Related Neurodegeneration
  • Mitochondria Quality Control and Parkinson’s Disease
  • New generation allosteric modulators of purinergic signalling for anti-tumour therapy
  • Autophagy signalling mechanisms
  • Evaluation and development of the patient-centred approach to teaching pharmacology